LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma

Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143

(2018) Qing An et al.   BIOMEDICINE & PHARMACOTHERAPY

Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance

(2018) Zhennan Yuan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers

(2018) Mohamad Moustafa Ali et al.   Nature Communications

The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer

(2018) Luqing Zhao et al.   CELLULAR SIGNALLING

Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer

(2017) Hu YiRen et al.   Molecular Cancer

Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes

(2017) Dongbo Zhou et al.   Molecular Medicine Reports

DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression

(2016) M. Borghesan et al.   CANCER RESEARCH

Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference

(2016) YI ZHANG et al.   ONCOLOGY REPORTS

STAT1 inhibits human hepatocellular carcinoma cell growth through induction of p53 and Fbxw7

(2015) Jiayu Chen et al.   Cancer Cell International

Low Expression of miR-448 Induces EMT and Promotes Invasion by Regulating ROCK2 in Hepatocellular Carcinoma

(2015) Huaqiang Zhu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Circulating Hepatocellular Carcinoma Cells are Characterized by CXCR4 and MMP26

(2015) Chang Yu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

(2015) Jessica Lo et al.   HEPATOLOGY

A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

(2015) Yu Yang et al.   LIVER INTERNATIONAL

Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2

(2015) Ming-De Huang et al.   Molecular Cancer

LEIGClong non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition

(2014) Yuehua Han et al.   BMC CANCER

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study

(2014) Mario Scartozzi et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of Transmembrane Protein 98 as a Novel Chemoresistance-Conferring Gene in Hepatocellular Carcinoma

(2014) K. T.-P. Ng et al.   MOLECULAR CANCER THERAPEUTICS

Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma

(2013) Yang Deng et al.   CANCER LETTERS

The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression

(2013) Suna Zhou et al.   DIGESTIVE DISEASES AND SCIENCES

The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell

(2013) Yong Yang et al.   PLoS One

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma

(2012) Igor P. Pogribny et al.   CANCER LETTERS